Table. Patient Baseline Characteristics.
| Characteristic | Value, No. (%) (N = 48)a |
|---|---|
| Age, mean (SD), y | 59.4 (15.2) |
| Sex | |
| Men | 35 (72.9) |
| Women | 13 (27.1) |
| p16 Test status | |
| Positive | 21 (43.8) |
| Negative | 2 (4.2) |
| Not tested | 26 (54.2) |
| HPV test status | |
| Type 16 | 20 (41.7) |
| Type 35 | 2 (4.2) |
| Type 69 | 1 (2.1) |
| Negative | 2 (4.2) |
| Not tested | 24 (50.0) |
| Diagnosis | |
| SCC | |
| HPV related | 23 (47.9) |
| Not HPV related | 12 (25.0) |
| Otherb | 10 (20.8) |
| No tumor or residual invasive disease found | 3 (6.3) |
Abbreviations: HPV, human papillomavirus; SCC, squamous cell carcinoma.
a
Data were available for 48 patients.
b
Other diagnoses included reactive lymphoid hyperplasia (3 patients), cellular pleomorphic adenoma (1 patient), diffuse large B cell lymphoma (1 patient), epithelial hyperplasia (1 patient), invasive malignant melanoma (1 patient), lymphangioma (1 patient), squamous dysplasia (1 patient), and squamous papilloma (1 patient).